Ascent Industries vs Ingevity
ACNT and NGVT side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACNT and NGVT compare
Ingevity is the larger company, worth 18 times as much as Ascent Industries ($2.1B against $117M).
Ascent Industries grew revenue faster over the last twelve months (22.4% versus −3.7% for Ingevity).
Ingevity keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with −1.0% at Ascent Industries.
Ascent Industries scores higher on the StockData Score (12 against 6 for Ingevity), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACNT | NGVT |
|---|---|---|
| Size and price | ||
| Market cap | $117M | $2.1B |
| Share price | $13.02 | $61.72 |
| Change, 1 year | −4.9% | 25.6% |
| Change, 5 years | −2.7% | −21.7% |
| Beta (5Y) | 0.34 | 1.21 |
| Employees | 198 | 1,500 |
| StockData Score | ||
| Total score | 12 (better) | 6 |
| Valuation score | 2 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 3 | 3 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 36.3× |
| P/S | 1.3× (better) | 1.9× |
| P/B | 1.4× (better) | 33.7× |
| EV/EBITDA | – | 23.1× |
| P/FCF | – | 17.3× |
| FCF yield | −6.7% | 5.8% (better) |
| Fair value | $14.67 | $35.71 |
| Margin of safety | 11.3% (better) | −72.8% |
| Growth | ||
| Revenue growth (TTM) | 22.4% (better) | −3.7% |
| Revenue growth, 5Y average | −21.8% | −0.81% (better) |
| Net income growth (TTM) | −208% | – |
| EPS growth (TTM) | −200% | – |
| Profitability | ||
| Gross margin | 20.8% | 42.0% (better) |
| Operating margin | −2.7% | – |
| Net margin | −1.0% | 5.3% (better) |
| FCF margin | −8.7% | 10.8% (better) |
| Return on equity | −1.1% | 59.5% (better) |
| Return on invested capital | −4.8% | – |
| Financial health | ||
| Debt / equity | 0.00 | 18.18 (better) |
| Net debt / EBITDA | – | 7.68 |
| Current ratio | 4.50 (better) | 1.48 |
| Altman Z-score | 4.59 (better) | 2.29 |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Years of dividend growth | 0 | – |
| Buyback yield | 6.1% | 7.4% (better) |
| Shareholder yield | 6.1% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 56.3% | 102% |
| Held by insiders | 13.8% | 1.4% |
| Insider net buying, 12 months | $123K (better) | −$1.8M |
| Short interest, % of float | 1.9% | 3.7% |
Go deeper
- ACNT stock overview
- ACNT income statement
- ACNT valuation and score
- NGVT stock overview
- NGVT income statement
- NGVT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.